| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 147.182 | 222.586 | 272.311 | 402.574 | 328.302 | 428.551 | 617.549 | 695.320 | 493.503 | 490.128 |
| Total Income - EUR | 158.566 | 223.386 | 272.311 | 403.402 | 328.302 | 428.576 | 617.549 | 695.320 | 493.503 | 490.128 |
| Total Expenses - EUR | 115.019 | 106.939 | 110.374 | 145.462 | 156.116 | 304.993 | 305.816 | 365.495 | 351.791 | 272.513 |
| Gross Profit/Loss - EUR | 43.546 | 116.447 | 161.937 | 257.940 | 172.185 | 123.583 | 311.734 | 329.825 | 141.712 | 217.615 |
| Net Profit/Loss - EUR | 36.215 | 97.438 | 156.771 | 253.914 | 168.902 | 119.601 | 305.558 | 324.523 | 138.102 | 203.206 |
| Employees | 5 | 11 | 5 | 6 | 12 | 8 | 11 | 11 | 10 | 9 |
Check the financial reports for the company - Mediproct Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.667 | 23.381 | 107.351 | 269.170 | 293.441 | 321.983 | 277.903 | 268.682 | 237.832 | 205.259 |
| Current Assets | 38.800 | 83.114 | 17.092 | 76.464 | 92.594 | 70.837 | 46.107 | 59.632 | 226.797 | 130.315 |
| Inventories | 256 | 644 | 390 | 21.992 | 36.977 | 1.924 | 1.436 | 257 | 687 | 774 |
| Receivables | 364 | 0 | 93 | 839 | 2.448 | 5.985 | 6.823 | 3.815 | 9.901 | 13.212 |
| Cash | 38.179 | 82.471 | 16.609 | 53.632 | 53.169 | 62.928 | 37.848 | 55.560 | 216.209 | 116.330 |
| Shareholders Funds | 36.269 | 97.492 | 156.823 | 407.859 | 451.592 | 392.990 | 323.845 | 324.571 | 461.689 | 203.254 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.503 | 9.004 | 22.071 | 10.245 | 6.136 | 11.597 | 14.407 | 12.301 | 11.472 | 140.805 |
| Income in Advance | 740 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mediproct Srl